சீனா வாழ்க்கை சுகாதாரம் நிதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சீனா வாழ்க்கை சுகாதாரம் நிதி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சீனா வாழ்க்கை சுகாதாரம் நிதி Today - Breaking & Trending Today

Canada's Virogin raises $120m led by China Life; to use proceeds for Shanghai R&D centre

Canada's Virogin raises $120m led by China Life; to use proceeds for Shanghai R&D centre
dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.

British Columbia , Chris Huang , William Jia , Linden Asset Group , China Life Healthcare Fund , China Structural Reform Fund , Shenzhen Capital Group , Virogin Biotech , China Life , China Life Healthcare , China Securities , Panlin Capital , China Structural Reform , பிரிட்டிஷ் கொலம்பியா , கிறிஸ் ஹுவாங் , லிண்டன் சொத்து குழு , சீனா வாழ்க்கை சுகாதாரம் நிதி , சீனா கட்டமைப்பு சீர்திருத்தம் நிதி , ஷென்சென் மூலதனம் குழு , சீனா வாழ்க்கை , சீனா வாழ்க்கை சுகாதாரம் , சீனா பத்திரங்கள் , பான்லின் மூலதனம் , சீனா கட்டமைப்பு சீர்திருத்தம் ,

China's medical equipment provider Jenscare secures funding co-led by GL Ventures

Primavera Capital, which had led an undisclosed Series B round funding in Jenscare, acted as the co-lead investor in the latest round. ....

Hong Kong , China Life Healthcare Fund , Agricultural Bank , Ningbo Jenscare Biotechnologyco Ltd , China Securities Regulatory Commission On , Jenscare Scientific , Ningbo Jenscare Biotechnologyco , Hillhouse Capital , China Asset Management , Forebright Capital , Futurex Capital , China Securities Regulatory Commission , ஹாங் காங் , சீனா வாழ்க்கை சுகாதாரம் நிதி , சீனா பத்திரங்கள் ஒழுங்குமுறை தரகு ஆன் , ஹில்ஹவுஸ் மூலதனம் , சீனா சொத்து மேலாண்மை , சீனா பத்திரங்கள் ஒழுங்குமுறை தரகு ,

GeneQuantum Raises Hundreds of Millions RMB in Series C Funding

GeneQuantum Raises Hundreds of Millions RMB in Series C Funding
News provided by
Share this article
Share this article
SUZHOU, China, May 18, 2021 /PRNewswire/ GeneQuantum Healthcare (Suzhou) Co., Ltd. (hereinafter GeneQuantum ) announced the completion of Series C fund raising of several hundreds of millions RMB. This series of fund raising is led by China Life Private Equity Investment, jointly by PICC Capital Equity Investment, Sunshine Guojian and Suzhou Wuzhong Biomedicine Industrial Park Investment. The current fund raising will provide a solid financial foundation to GeneQuantum for its global clinical development and pipeline expansion of next generation site-specific bioconjugates.
Since its establishment, GeneQuantum has focused on the development of innovative bioconjugate drugs represented by Antibody-Drug-Conjugate (ADC). We possess highly differentiated ADC technology platforms, including enzyme catalyzed site-specific conjugation technol ....

Guo Jian , Gang Qin , Lerming Pharma , Leidi Zhang , Innovation Fund , Healthcare Fund , Investment Co Ltd , Genequantum Healthcare Suzhou Co Ltd , Rendong Holding , Suzhou Direct Investment Fund , China Life Health Foundation , Capital Equity Investment Company Limited , China Life Healthcare Fund , Sector Fund , Technological Development Zone , Wuzhong Biomedicine Industrial Park Investment Co Ltd , Prnewswire Genequantum Healthcare Suzhou Co Ltd , China Life Health Fund , Quantum Healthcare , China Life Private Equity Investment , Equity Investment , Sunshine Guojian , China Life , Life Health Foundation , Genequantum Healthcare , Life Health Fund ,

DCP, Sequoia China lead Series B round for medical devices firm Valgen

DCP, Sequoia China lead Series B round for medical devices firm Valgen
Source: Valgen Medtech
May 6, 2021
Greater China-focused private equity firm DCP and tech investment bellwether Sequoia Capital China have co-led a Series B round of financing for Valgen Medtech, a developer of treatment technologies for heart diseases in China. The investment size is said to be “hundreds of millions of US dollars.”
Lake Bleu Capital, a healthcare-focused asset management platform; Chinese transcatheter heart valve medical devices maker Venus Medtech; China Life Healthcare Fund, an investment vehicle of Beijing-based insurer China Life Insurance; Hong Kong’s healthcare investor Ascendum Capital participated in the round. Existing shareholder Qiming Venture Partners re-upped in the round. ....

Hong Kong , Valgen Medtech , Venus Medtech , China Life Healthcare Fund , Greater China Focused , Sequoia Capital China , Bleu Capital , China Life Insurance , Ascendum Capital , Qiming Venture Partners , Dinova Medtech , Hangzhou City , Biotrack Capital , ஹாங் காங் , வெள்ளி மெதிதேச் , சீனா வாழ்க்கை சுகாதாரம் நிதி , அதிகமானது சீனா கவனம் , சீக்வோயா மூலதனம் சீனா , ப்ளூ மூலதனம் , சீனா வாழ்க்கை காப்பீடு ,